Parkman Healthcare Partners LLC cut its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 3.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 237,762 shares of the medical research company’s stock after selling 8,050 shares during the period. Parkman Healthcare Partners LLC owned 0.19% […]